Vigabatrin
Adult Refractory Complex Partial Seizures
Lundbeck LLCSmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Adult Refractory Complex Partial Seizures cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
Vigabatrin is also rated in:
benign partial epilepsy of infancy with complex partial seizuresDormant
B
Indicative ·
62 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →